NCT00357604 - Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

HIV Infections

Interventions

DRUG

Ortho Tri-Cyclen (ethinyl estradiol + norgestimate)

Tablets, Oral, 35 mcg of EE + 0.18/0.215/0.25 mg of NGM, once daily, 28 days.

DRUG

Ortho Tri-Cyclen LO (ethinyl estradiol + norgestimate) + Atazanavir/Ritonavir for 14 days then Ortho Tri-Cyclen for 7 days

Tablets + Capsules/Capsules, Oral, (25 mcg of EE + 0.18/0.215/0.25 mg of NGM) + 300/100 mg then 35 mcg of EE + 0.18/0.215/0.25 mg of NGM, once daily, 21 days.

Trial Locations (1)

92123

Covance Cpu, Inc, San Diego